SalioGen Therapeutics logo

SalioGen Therapeutics

Cambridge, MA

SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to more patients with inherited diseases. Looking ahead, SalioGen will also explore the EDIT platform’s capabilities to streamline cell therapy, cell engineering, and biologics manufacturing to help an even broader population of patients in need.

saliogen.com

Company Details

Founded

2020

Employees

Between 50 - 200 employees

Raised

$135,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Jason ColeJason Cole

Founders

Joseph J. Higgins
Joseph J. Higgins

Company Collections

These are collections SalioGen Therapeutics is a part of. Click on the collection name to view similar companies.

SalioGen Therapeutics' Tech Stack